Search
Add filters:
Use filters to refine the search results.
Item hits:
Issue Date | Title | Author(s) |
---|---|---|
28-Jan-2014 | An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration. | Olson, Ashley D.; Meyer, Laurence; Prins, Maria; Thiebaut, Rodolphe; Gurdasani, Deepti; Guiguet, Marguerite; Chaix, Marie-Laure; Amornkul, Pauli N.; Babiker, Abdel; Sandhu, Manjinder S.; Porter, Kholoud; Gatell, José M. |
7-Nov-2012 | Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine | Álvarez Fernández, Carmen; Crespo Guardo, Alberto; García-Pérez, Javier; García Alcaide, Felipe; Blanco, Julià; Escribà-García, Laura; Gatell, José M.; Alcamí, José; Plana Prades, Montserrat; Sánchez-Palomino, Sonsoles |
2-Nov-2012 | Pharmacogenetics of efficacy and safety of HCV treatment in HCV-HIV coinfected patients: significant associations with IL28B and SOCS3 gene variants. | Vidal, Francesc; López Dupla, Miguel; Laguno Centeno, Montserrat; Veloso, Sergi; Mallolas Masferrer, Josep; Murillas Angoiti, Javier; Cifuentes, Carmen; Gallart, Lluis; Auguet, Teresa; Sampériz, Gloria; Payeras, Antoni; Hernandez, Pilar; Arnedo, Mireia; Gatell, José M.; Richart, Cristóbal |
11-Jun-2013 | Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse? | Millet, Joan-Pau; Shaw Perujo, Evelyn; Orcau i Palau, Àngels; Casals, Martí; Miró Meda, José M.; Caylà i Buqueras, Joan A.; Gatell, José M.; Tudó i Vilanova, Griselda; Barcelona Tuberculosis Recurrence Working Group |
4-Oct-2011 | Impact of switching from lopinavir/ritonavir to atazanavir/ritonavir on body fat redistribution in virologically suppressed HIV-infected adults | Ferrer, Elena; Río, Luis del; Martínez Chamorro, Esteban José; Curto, J. J. (Jorge Juan); Domingo, Pere (Domingo Pedrol); Ribera, Esteban; Negredo, Eugènia; Rosales, Joaquín; Saumoy, Maria; Ordóñez, J. (Jordi), 1952-; Gatell, José M.; Podzamczer Palter, Daniel |
2014 | Differential microRNA expression profile between stimulated PBMCs from HIV-1 infected elite controllers and viremic progressors | Egaña Gorroño, Lander; Escribà, Tuixent; Boulanger, Nicolas; Crespo Guardo, Alberto; León García, Agathe; Bargalló, Manel Enric; García, Felipe; Gatell, José M.; Plana Prades, Montserrat; Arnedo, Mireia |
28-May-2014 | Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation | Nordell, Anna D.; McKenna, Matthew; Borges, Álvaro H.; Duprez, Daniel; Neuhaus, Jacqueline; Neaton, James D.; Gatell, José M. |
2-Nov-2014 | Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study. | Cahn, Pedro; Villanueva, Andrade; Arribas, José Ramón; Gatell, José M.; Lama, Javier; Norton, Michel; Patterson, Patricia; Sierra Madero, Juan; Sued, Omar; Inés Figueroa, Maria; José Rolón, Maria |
2014 | Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients | Gatell, José M.; Morales Ramirez, Javier O.; Hagins, Debbie P.; Thompson, Melanie; Keikawus, Arasteh; Hoffmann, Christian; Rugina, Sorin; Osiyemi, Olayemi; Escoriu, Simona; Dretler, Robin; Harvey, Charlotte; Xu, Xia; Teppler, Hedy |
21-Aug-2012 | Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG | Saubí, Narcís; Mbewe-Mvula, Alice; Gea Mallorqui, Ester; Rosario, Maximillian; Gatell, José M.; Hanke, Tomás; Joseph, Joan |
Discover
Subject